In May 2025, the Journal for ImmunoTherapy of Cancer published a pioneering study entitled “NeoPred: dual-phase CT AI forecasts pathologic response to neoadjuvant chemo-immunotherapy in NSCLC”, led by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback